New Insight Wealth Advisors Invests $254,000 in UnitedHealth Group Incorporated $UNH

Key Points

• New Insight Wealth Advisors invested $254,000 in UnitedHealth Group by acquiring 814 shares during the second quarter.
• Analysts have downgraded UnitedHealth Group's stock ratings, with price targets ranging from $286 to $358.95 as they anticipate a Moderate Buy consensus.
• UnitedHealth Group reported quarterly earnings with $4.08 earnings per share, missing the consensus estimate of $4.45, despite a 12.9% year-over-year revenue increase.

New Insight Wealth Advisors acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 814 shares of the healthcare conglomerate's stock, valued at approximately $254,000.

Several other large investors have also recently modified their holdings of the stock. Bayforest Capital Ltd lifted its holdings in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its position in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after acquiring an additional 50 shares during the period. Copia Wealth Management bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $42,000. IAG Wealth Partners LLC bought a new stake in shares of UnitedHealth Group during the 1st quarter valued at $42,000. Finally, Kentucky Trust Co raised its position in shares of UnitedHealth Group by 53.8% during the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate's stock valued at $45,000 after buying an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analysts Set New Price Targets

Several brokerages have weighed in on UNH. Baird R W downgraded shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 31st. Piper Sandler decreased their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Royal Bank Of Canada decreased their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. KeyCorp decreased their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Finally, JPMorgan Chase & Co. reduced their target price on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a report on Wednesday, August 6th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $358.95.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $345.84 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm has a market capitalization of $313.22 billion, a price-to-earnings ratio of 14.98, a PEG ratio of 2.29 and a beta of 0.45. The company's 50-day moving average is $299.96 and its two-hundred day moving average is $361.40. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's revenue was up 12.9% on a year-over-year basis. During the same period last year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's dividend payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.